α-
Dystroglycan (α-DG) is a highly glycosylated
cell-surface protein. Defective O-mannosyl
glycan on α-DG is associated with
muscular dystrophies and
cancer. In the biosynthetic pathway of the O-mannosyl
glycan, fukutin (FKTN) and fukutin-related
protein (FKRP) transfer
ribitol phosphate (RboP). Previously, we reported that FKTN and FKRP can also transfer
glycerol phosphate (GroP) from
CDP-
glycerol (
CDP-Gro) and showed the inhibitory effects of
CDP-Gro on functional
glycan synthesis by preventing
glycan elongation in vitro. However, whether mammalian cells have
CDP-Gro or associated synthetic machinery has not been elucidated. Therefore, the function of
CDP-Gro in mammals is largely unknown. Here, we reveal that cultured human cells and mouse tissues contain
CDP-Gro using liquid chromatography tandem-mass spectrometry (LC-MS/MS). By performing the
enzyme activity assay of candidate
recombinant proteins, we found that
ethanolamine-phosphate cytidylyltransferase (PCYT2), the key
enzyme in de novo
phosphatidylethanolamine biosynthesis, has
CDP-Gro synthetic activity from glycerol-3-phosphate (Gro3P) and
CTP. In addition, knockdown of PCYT2 dramatically reduced cellular
CDP-Gro. These results indicate that PCYT2 is a
CDP-Gro synthase in mammals. Furthermore, we found that the expression of functionally glycosylated α-DG is increased by reducing PCYT2 expression. Our results suggest an important role for
CDP-Gro in the regulation of α-DG function in mammals.